SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM • FR0013154002

167.05 EUR
-12.65 (-7.04%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall DIM gets a fundamental rating of 4 out of 10. We evaluated DIM against 18 industry peers in the Life Sciences Tools & Services industry. DIM has only an average score on both its financial health and profitability. DIM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DIM had positive earnings in the past year.
  • DIM had a positive operating cash flow in the past year.
  • DIM had positive earnings in 4 of the past 5 years.
  • DIM had a positive operating cash flow in 4 of the past 5 years.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • DIM has a Return On Assets of 3.36%. This is in the lower half of the industry: DIM underperforms 61.11% of its industry peers.
  • DIM has a Return On Equity (6.55%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.94%, DIM is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DIM is in line with the industry average of 9.64%.
  • The last Return On Invested Capital (5.94%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROIC 5.94%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • DIM has a better Profit Margin (8.98%) than 61.11% of its industry peers.
  • In the last couple of years the Profit Margin of DIM has declined.
  • DIM has a better Operating Margin (16.63%) than 66.67% of its industry peers.
  • DIM's Operating Margin has declined in the last couple of years.
  • The Gross Margin of DIM (45.64%) is better than 61.11% of its industry peers.
  • In the last couple of years the Gross Margin of DIM has declined.
Industry RankSector Rank
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DIM is still creating some value.
  • DIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • DIM has an Altman-Z score of 4.03. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of DIM (4.03) is better than 77.78% of its industry peers.
  • DIM has a debt to FCF ratio of 6.84. This is a slightly negative value and a sign of low solvency as DIM would need 6.84 years to pay back of all of its debts.
  • The Debt to FCF ratio of DIM (6.84) is better than 61.11% of its industry peers.
  • A Debt/Equity ratio of 0.50 indicates that DIM is not too dependend on debt financing.
  • The Debt to Equity ratio of DIM (0.50) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Altman-Z 4.03
ROIC/WACC0.64
WACC9.22%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • DIM has a Current Ratio of 1.05. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
  • DIM has a worse Current ratio (1.05) than 61.11% of its industry peers.
  • DIM has a Quick Ratio of 1.05. This is a bad value and indicates that DIM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DIM has a Quick ratio of 0.50. This is in the lower half of the industry: DIM underperforms 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.5
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • DIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.71%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 1.13% on average over the past years.
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.78%

3.2 Future

  • Based on estimates for the next years, DIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.33% on average per year.
  • DIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.84% yearly.
EPS Next Y21.28%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
EPS Next 5Y18.33%
Revenue Next Year7.74%
Revenue Next 2Y9.23%
Revenue Next 3Y9.67%
Revenue Next 5Y10.84%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 37.97 indicates a quite expensive valuation of DIM.
  • Based on the Price/Earnings ratio, DIM is valued a bit more expensive than 72.22% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of DIM to the average of the S&P500 Index (26.83), we can say DIM is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 31.30 indicates a quite expensive valuation of DIM.
  • Based on the Price/Forward Earnings ratio, DIM is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • DIM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 37.97
Fwd PE 31.3
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DIM is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DIM.
Industry RankSector Rank
P/FCF 43.4
EV/EBITDA 24.44
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as DIM's earnings are expected to grow with 22.34% in the coming years.
PEG (NY)1.78
PEG (5Y)33.65
EPS Next 2Y21.44%
EPS Next 3Y22.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.38%, DIM is not a good candidate for dividend investing.
  • In the last 3 months the price of DIM has falen by -21.68%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.44, DIM has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

  • The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • DIM pays out 25.37% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.37%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SARTORIUS STEDIM BIOTECH

EPA:DIM (3/3/2026, 7:00:00 PM)

167.05

-12.65 (-7.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)N/A
Inst Owners11.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.26B
Revenue(TTM)N/A
Net Income(TTM)264.50M
Analysts78.95
Price Target241.58 (44.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP25.37%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.99%
Min EPS beat(2)-2.24%
Max EPS beat(2)10.22%
EPS beat(4)3
Avg EPS beat(4)9.45%
Min EPS beat(4)-2.24%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.58%
EPS beat(12)3
Avg EPS beat(12)-11.08%
EPS beat(16)4
Avg EPS beat(16)-13.1%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.94%
Max Revenue beat(2)0.3%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)7
Avg Revenue beat(16)-0.72%
PT rev (1m)-2.32%
PT rev (3m)1.15%
EPS NQ rev (1m)-0.7%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0.65%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-0.49%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 37.97
Fwd PE 31.3
P/S 5.52
P/FCF 43.4
P/OCF 22.25
P/B 4.03
P/tB N/A
EV/EBITDA 24.44
EPS(TTM)4.4
EY2.63%
EPS(NY)5.34
Fwd EY3.19%
FCF(TTM)3.85
FCFY2.3%
OCF(TTM)7.51
OCFY4.49%
SpS30.27
BVpS41.47
TBVpS-4.02
PEG (NY)1.78
PEG (5Y)33.65
Graham Number64.07
Profitability
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROCE 7.46%
ROIC 5.94%
ROICexc 6.26%
ROICexgc 21.64%
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
FCFM 12.71%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexgc growth 3Y-36.77%
ROICexgc growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Debt/EBITDA 2.5
Cap/Depr 112.98%
Cap/Sales 12.09%
Interest Coverage 3.09
Cash Conversion 90.75%
Profit Quality 141.63%
Current Ratio 1.05
Quick Ratio 0.5
Altman-Z 4.03
F-Score8
WACC9.22%
ROIC/WACC0.64
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
EPS Next Y21.28%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
EPS Next 5Y18.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.78%
Revenue Next Year7.74%
Revenue Next 2Y9.23%
Revenue Next 3Y9.67%
Revenue Next 5Y10.84%
EBIT growth 1Y25.48%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year93.68%
EBIT Next 3Y34.9%
EBIT Next 5Y26.76%
FCF growth 1Y219.35%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y15.98%
OCF growth 3Y5.11%
OCF growth 5Y21.32%

SARTORIUS STEDIM BIOTECH / DIM.PA FAQ

What is the fundamental rating for DIM stock?

ChartMill assigns a fundamental rating of 4 / 10 to DIM.PA.


What is the valuation status of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.


What is the profitability of DIM stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (DIM.PA) is 37.97 and the Price/Book (PB) ratio is 4.03.


What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?

The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (DIM.PA) is expected to grow by 21.28% in the next year.